Ads
related to: paid clinical trials- Find a Location
Get Directions To The James
Locations in Central Ohio
- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- Follow the Blog
Get The Latest News
And Updates from The James
- Treat Cancer & Diagnose
The James is Home to
World-Renowned Cancer Experts
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Immunotherapy Management
Proactively mitigating side effects
Well-being beyond cancer treatment
- Find a Location
Search results
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ in COVID vaccine trial
New York Post· 20 hours ago“I walked into the... claims she had signed a consent form with the manufacturer at the beginning of...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 1 day agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Talphera Inc (TLPH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...
GuruFocus.com via Yahoo Finance· 56 minutes agoDespite a revenue-free quarter, Talphera Inc (TLPH) progresses in clinical trials and secures significant funding, setting a robust groundwork for future growth.
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 52 minutes agoDespite strong growth, Arcutis Biotherapeutics Inc (NASDAQ:ARQT) faces challenges with the typical co-pay resets and insurance changes that can impact gross-to-net improvements ...
Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials By Investing.com
Investing.com· 4 days agoCassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company, announced a profitable...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials By Investing.com
Investing.com· 6 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL) held its fiscal 2024 second-quarter earnings call,...
Earnings call: MiNK Therapeutics advances in cancer therapy programs By Investing.com
Investing.com· 14 hours agoThe company's CAR iNKT Cell Therapy, MiNK-215, targeting solid tumors, has received significant...
Earnings call: Protalix BioTherapeutics Q1 2024 financial results By Investing.com
Investing.com· 5 days agoProtalix BioTherapeutics, Inc. (PLX) has reported its first-quarter financial results for 2024,...
Zentalis shares target cut, retains buy rating on ongoing azenosertib clinical trials By...
Investing.com· 7 days agoWainwright, with the firm reducing the target to $40.00 from the previous $46.00 while maintaining a...
Earnings call: INOVIO outlines 2024 plans, reports Q1 financials
Investing.com· 1 day agoINOVIO Pharmaceuticals Inc. ( NASDAQ : INO), a biotechnology company, has reported its financial...